Primary treatments for metastatic breast cancer are chemotherapy and radiation therapy, and surgery is reserved for tumor related complications such as bleeding. Retrospective studies showed that surgical removal of the primary tumor improves survival of patients with metastatic breast cancer at diagnosis. We hypothesis and testing that surgical removal of the primary tumor will lead to an improvement of overall survival
This is a randomised, controled clinical trial. Our aim is to observe whether primary surgery improves survival in metastatic breast cancer. Women who have metastatic breast cancer at the initial diagnosis will be included in the study. There will be two study arms: primary surgery and systemic chemotherapy groups. In the primary surgery group patients will have adjuvant therapies after they had the proper surgery. In the systemic chemotherapy group patients will be followed after their initial therapy and will have surgery only if they have locoregional problems (such as wide necrosis or bleeding, etc). During the follow-up period, patients will be seen in every 6 months.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
281
Primary breast surgery before systemic therapy
Cukurova University
Adana, Turkey (Türkiye)
Ankara Onkoloji Hastanesi
Ankara, Turkey (Türkiye)
Adnan Menderes University
Aydin, Turkey (Türkiye)
Izzet Baysal University
Bolu, Turkey (Türkiye)
Measure: all cause mortality
Time frame: 5 years
Quality of life
Time frame: 5 year
mordities
Time frame: 5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Istanbul University Medical faculty
Istanbul, Turkey (Türkiye)
Marmara Univesity School of Medicine
Istanbul, Turkey (Türkiye)
Cumhuriyet University Medical School
Sivas, Turkey (Türkiye)